Monitoring temperature remotely in cancer patients at risk for fever

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program evaluates the effectiveness of remote temperature monitoring in cancer patients who are at risk of developing fever due to chemotherapy. Participants will wear a thermometer that continuously tracks their temperature and sends alerts to their phones if it exceeds a certain threshold. The study aims to determine if this monitoring can reduce hospital stays and assess the associated costs and billing codes. Researchers will compare patients who comply with the monitoring to those who do not to evaluate the impact on inpatient days.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject is at risk of a fever post discharge.
* Subject is ≥ 18 years or older.
* Subject has an iOS or Android phone, or is able to operate an AION provided smartphone device.
* Subject is willing to install the TempShield app on his/her phone.
* Subject is willing to allow AION to send text reminders to take temperature or complete surveys.
* Subject is willing to take an oral temperature as directed by their care plan.
* Subject is willing to configure the phone to ensure these notifications are delivered, even when phone is in a "no notification" mode.
* Subject or subject caretaker is able and willing to complete subject surveys.
* Subject is willing and able to provide written informed consent in English.
* Subject is willing and able to comply with all program procedures, requirements, assessments, visits, and complete questionnaires.
* English speakers

Exclusion Criteria:

* Unable to provide informed consent
* Subjects with a history of Medical Adhesive-Related Skin Injury (MARSI)
* Subjects with no available placement that avoids open wounds or traumatized skin (burns. Blisters. Etc.)
* Non-English speakers: The mobile application is only currently available in English. Future development will include other languages.
* Subjects receiving prophylactics that could induce fever.
* Subjects with a silicon allergy
* Subject does not have iOS or Android phone, and is unable to operate an AION provided smartphone device.
* Subjects who are not willing to take an oral temperature per their care plan.

Where it's running

• Ellis Hospital
  Schenectady, New York, United States Recruiting

Study contacts

• Principal investigator: Tallat Mahmood, M.D. — Ellis Hospital
• Study coordinator: David Colburn, Ph.D.
• Email: d.alexander.colburn@aionbioystems.com
• Phone: (757) 641-2019

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• See if Buzzy and virtual reality help kids get IV lines faster

  This study tests whether a vein-imaging device plus virtual reality or the same device plus a pain-reducing tool can make peripheral IV placement easier for children aged 7–12 with fever.

  Recruiting Bandırma Onyedi Eylül University · Bursa · NCT07882602

• Triage performance and physiological predictors of serious illness in febrile children in the pediatric emergency department

  This study tests whether the initial color-coded triage category and vital signs at triage can predict serious outcomes in febrile children who come to pediatric emergency departments in Turkey.

  Recruiting at 10 sites TC Erciyes University · Kayseri, Talas and 9 other locations · NCT07739004

• BloodTrackR Usability and Concordance in RA

  This study tests a home blood collection device and accompanying app for people with rheumatoid arthritis to see if they can collect usable samples at home and whether the results match standard blood tests.

  Recruiting University of Ulster · Londonderry · NCT07660029

• Remote-patient monitoring in diabetes care shows real-world outcomes

  A real-world, pre-post observational study at Steno Diabetes Center Copenhagen tests whether adding remote-patient-monitoring within the EHR can maintain glycemic outcomes over two years for about 12,000 people with diabetes compared with prior ambulatory care.

  Recruiting Steno Diabetes Center Copenhagen · Herlev · NCT07617519

• Turning anonymous symptom descriptions into structured biological signals with OpenGenome

  This project tries to turn adults' anonymous free-text symptom descriptions submitted to OpenGenome into structured, literature-grounded biological signals using PubMed and ClinicalTrials.gov sources and a constrained reasoning model.

  Recruiting OpenGenome · Friedrichshain, State of Berlin · NCT07578610

• How long to take sulfamethoxazole after a kidney transplant

  This study will test whether different lengths of sulfamethoxazole (TMP‑SMX) taken after a kidney transplant better prevent Pneumocystis jirovecii pneumonia in adult transplant recipients.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07231770

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.